Damian Kovalovsky

4PUBLICATIONS
14CO-AUTHORS
Innate immunityTumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Nov 15, 2024
The HDAC6 inhibitor AVS100 (SS208) induces a pro-inflammatory tumor microenvironment and potentiates immunotherapy.

Damian Kovalovsky, Satish Noonepalle, Manasa Suresh

|May 06, 2022
Zbtb20 identifies and controls a thymus-derived population of regulatory T cells that play a role in intestinal homeostasis.

Agata K Krzyzanowska, Rashade A H Haynes Ii, Damian Kovalovsky

|Feb 15, 2022
Increased Activity of a NK-Specific CAR-NK Framework Targeting CD3 and CD5 for T-Cell Leukemias.

Elisaveta Voynova, Nga Hawk, Francis A Flomerfelt

|Feb 26, 2021
Siglec-6 is a target for chimeric antigen receptor T-cell treatment of chronic lymphocytic leukemia.

Damian Kovalovsky, Jeong Heon Yoon, Matthew G Cyr

Pageof 1